Clinical trial

A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects

NCT02211469

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-08-01

PhasePHASE1

Study timeline

Study start (unknown)2014-08-01Date precision: month

Registry last updated2015-09-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

BMS-986104DRUG

PlaceboDRUG

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

MadisonWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02211469 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.